ARTICLE | Company News
Pharmexa spins out Inoxell
May 30, 2001 7:00 AM UTC
Pharmexa (CSE:MEBIO), formerly M&E Biotech, has spun out a new genomics company Inoxell, based on its CellScreen technology for identification of validated targets by genetic manipulation of intracell...